"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 2 | 1 | 3 |
| 2001 | 3 | 0 | 3 |
| 2002 | 1 | 1 | 2 |
| 2003 | 7 | 1 | 8 |
| 2004 | 3 | 0 | 3 |
| 2005 | 4 | 1 | 5 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 3 | 0 | 3 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 2 | 2 | 4 |
| 2013 | 3 | 2 | 5 |
| 2014 | 2 | 0 | 2 |
| 2015 | 7 | 2 | 9 |
| 2016 | 8 | 1 | 9 |
| 2017 | 4 | 3 | 7 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 4 | 6 |
| 2020 | 7 | 5 | 12 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 3 | 4 |
| 2023 | 2 | 1 | 3 |
| 2024 | 2 | 2 | 4 |
| 2025 | 2 | 3 | 5 |
| 2026 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Durability of doxycycline effectiveness against gonorrhoea after implementation of post-exposure prophylaxis in southern California, USA: a retrospective, test-negative, observational study. Lancet Infect Dis. 2026 Aug; 26(8):819-831.
-
Association between Broad-Spectrum Antibiotic Use and Risk of Early-Onset Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2026 Apr 01; 35(4):637-646.
-
Acne Incidence and Severity in Transgender Individuals. JAMA Dermatol. 2026 Mar 01; 162(3):255-263.
-
Use of and Outcomes Related to Intrapleural Enzyme Therapy for Complicated Parapneumonic Effusion and Empyema in an Integrated Health System. Chest. 2026 Apr; 169(4):1115-1123.
-
Emergency department triage associated with timeliness of care for patients with septic shock. Am J Emerg Med. 2025 12; 98:330-333.
-
Anti-biofilm and anti-infection activities of Lynronne-1 against major bovine mastitis pathogens. Microb Pathog. 2025 Dec; 209:108107.
-
Outcomes of Asynchronous e-Visits vs. Telephone or Video Visits for Common Primary Care Concerns. J Gen Intern Med. 2025 Nov; 40(14):3371-3378.
-
Monitoring strategies and vancomycin-associated acute kidney injury in patients treated at home. J Antimicrob Chemother. 2025 May 02; 80(5):1386-1393.
-
Validation of Lactational Mastitis Diagnosis Codes in Electronic Health Care Data. Epidemiology. 2025 Mar 01; 36(2):160-164.
-
Antimicrobial prescribing practices for enteric bacterial infections in an integrated health care system, Wisconsin, 2004-2017. J Infect Public Health. 2025 Jan; 18(1):102613.